Cover Image
市場調查報告書

神經血管裝置/介入神經放射學的全球市場預測 2021年:栓塞線圈、支架、腦血栓消除設備、微導管、球囊阻塞設備、血流迂迴設備、血栓回收

Neurovascular Devices/Interventional Neurology Market by Product (Embolic Coils, Stents, Neurothrombectomy Devices, Microcatheters, Balloon Occlusion Devices, Flow Diversion Devices, Clot Retrievers), Pathology (Aneurysm, AVM) - Global Forecasts to 2021

出版商 MarketsandMarkets 商品編碼 253839
出版日期 內容資訊 英文 195 Pages
訂單完成後即時交付
價格
Back to Top
神經血管裝置/介入神經放射學的全球市場預測 2021年:栓塞線圈、支架、腦血栓消除設備、微導管、球囊阻塞設備、血流迂迴設備、血栓回收 Neurovascular Devices/Interventional Neurology Market by Product (Embolic Coils, Stents, Neurothrombectomy Devices, Microcatheters, Balloon Occlusion Devices, Flow Diversion Devices, Clot Retrievers), Pathology (Aneurysm, AVM) - Global Forecasts to 2021
出版日期: 2017年03月01日 內容資訊: 英文 195 Pages
簡介

全球神經血管裝置/介入神經放射學市場規模,預計從2016年到2021年以8.6%的年複合成長率擴大,達到26億2,000萬美元。

本報告提供全球神經血管裝置/介入神經放射學市場相關調查分析,各產品、疾病病情及各地區的市場考察,以及競爭情形,主要企業簡介等相關彙整,為您概述為以下內容。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 神經血管裝置/介入神經放射學市場概要
  • 全球神經血管裝置/介入神經放射學產品市場:各地區
  • 全球神經血管裝置/介入神經放射學產品市場
  • 全球神經血管裝置/介入神經放射學產品市場:各疾病病情,各地區
  • D神經血管裝置/介入神經放射學產品市場:各國

第5章 市場概要

  • 簡介
  • 市場動態
    • 推動市場要素
    • 市場抑制因素
    • 市場機會
  • 現在進行中的臨床研究
    • 栓塞線圈治療
    • 頸動脈支架治療
    • 栓塞保護治療
    • 血流迂迴
    • 支援技術
    • 腦血栓消除治療

第6章 產業考察

  • 簡介
  • 供應鏈分析
  • 波特的五力分析
  • 產業趨勢

第7章 神經血管裝置/介入神經放射學市場:各產品

  • 簡介
  • 動脈瘤線圈 & 栓塞設備
    • 栓塞線圈
    • 血流迂迴設備
    • 液體栓塞物質
  • 腦動脈球囊血管新生、支架系統
    • 頸動脈支架
    • 栓塞保護系統
  • 支援設備
    • 微導管
    • 微導管導引線
  • 腦血栓消除設備
    • 血栓回收設備
    • 吸引設備
    • 鉉圈套器

第8章 全球神經血管裝置/介入神經放射學產品市場:各疾病病情

  • 簡介
  • 缺血性中風
  • 腦動脈瘤
  • 動靜脈畸形、動靜脈瘺
  • 其他

第9章 全球神經血管裝置/介入神經放射學產品市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他各國

第10章 競爭情形

  • 概要
  • 市場佔有率分析
  • 競爭模式
  • 最新趨勢

第11章 企業簡介

  • 簡介
  • STRYKER CORPORATION
  • MEDTRONIC PLC
  • JOHNSON & JOHNSON
  • TERUMO CORPORATION
  • PENUMBRA, INC.
  • BOSTON SCIENTIFIC CORPORATION
  • MICROPORT SCIENTIFIC CORPORATION
  • MERIT MEDICAL SYSTEMS, INC.
  • W.L. GORE & ASSOCIATES, INC.
  • ABBOTT LABORATORIES

第12章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MD 1310

The global neurovascular devices/interventional neurology market is estimated reach USD 2.62 million at a CAGR of 8.6% during 2016-2021. As of 2016, North America and Europe holds the largest share of the market; however, the Asia-Pacific region is poised to be the fastest growing region during next five years owing to factors such as the presence of a large patient population base for target diseases, rising awareness among neurosurgeons related to the benefits offered by interventional neurology devices, ongoing government initiatives to modernize & expand healthcare infrastructure, and increasing adoption of neurovascular devices due to decreasing product price (owing to increasingly localized manufacturing and strengthening of distribution networks).

Market growth in the market is mainly driven by factors such as large target patient population base, ongoing product development & commercialization, favorable medical reimbursements, expansion of healthcare infrastructure across emerging markets and growing market demand for effective neurovascular devices. The factors such as the increasing number of research activities in the field of neurovascular therapies and rising demand for minimally invasive neurosurgical procedures are expected to offer renewed growth opportunities for the market players during the forecast period.

Geographically, North America is estimated to command the largest share of the global market in 2016, followed by Europe. The large market share of the North American region can be attributed to increasing adoption of neurovascular devices among neurosurgeons in neurovascular disease treatment, the growing number of clinical trials (that aim to evaluate the therapeutic efficacy of neurovascular devices in specific disease treatment), significant medical reimbursement available in the U.S. for neurosurgical procedures, large patient population for target diseases, favorable reimbursement scenario, strong presence of device manufacturers in the region, and availability of significant R&D investments to support neurovascular product development. However, market growth will be negatively affected due to the unfavorable regulatory scenario in the region, which may result in increased pricing pressure on key neurovascular device manufacturers.

The market is highly competitive, with a large number of global and local manufacturers of neurovascular products. Stryker Corporation (U.S.), Medtronic Plc (Ireland), and Johnson & Johnson (U.S.) were the top three players in the market, in 2015.

Report Objectives:

This report studies neurovascular devices/interventional neurology market based on products, disease pathology, and region.

The report also studies, the factors (such as drivers, restraints, opportunities, and challenges) which affect the market growth in a positive and negative manner. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the neurovascular devices/interventional neurology market report analyzes the micromarkets with respect to their individual growth trends, prospects, and contributions to the neurovascular devices/interventional neurology market.

Reasons to Buy the Report:

From an insights perspective, this research report is focused on various levels of analysis-industry trends, market share analysis of top ten players, and company profiles, which together discuss basic views on the competitive landscape, emerging and high growth segments of the neurovascular devices/interventional neurology market, and high growth regions and their respective drivers, restraints, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering greater market shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the major players in the neurovascular devices/interventional neurology market. The report analyzes the market based on product, disease pathology, and region.
  • Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and product launches in the neurovascular devices/interventional neurology market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various neurovascular devices/interventional neurology products across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the neurovascular devices/interventional neurology market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the neurovascular devices/interventional neurology market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Breakdown of primaries
  • 2.2. OPPORTUNITY INDICATORS
      • 2.2.1.1. Target disease prevalence
      • 2.2.1.2. Rising geriatric population
      • 2.2.1.3. Number of hospitals and surgical centers
      • 2.2.1.4. Healthcare expenditure
      • 2.2.1.5. Increasing clinical research
  • 2.3. MARKET SIZE ESTIMATION
    • 2.3.1. BOTTOM-UP APPROACH
    • 2.3.2. TOP-DOWN APPROACH
  • 2.4. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.5. RESEARCH ASSUMPTIONS
    • 2.5.1. ASSUMPTIONS

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET OVERVIEW
  • 4.2. GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY PRODUCT MARKET, BY REGION (2016 VS. 2021)
  • 4.3. GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY PRODUCT (2016 VS. 2021)
  • 4.4. GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET FOR DISEASE PATHOLOGY, BY REGION (2016-2021)
  • 4.5. NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY COUNTRY (2016 VS. 2021)

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. KEY MARKET DRIVERS
      • 5.2.1.1. Large target patient population
      • 5.2.1.2. Ongoing product development and commercialization
      • 5.2.1.3. Favorable medical reimbursements
      • 5.2.1.4. Expansion of healthcare infrastructure across emerging markets
      • 5.2.1.5. Growing market demand for effective neurovascular devices
    • 5.2.2. KEY MARKET RESTRAINTS
      • 5.2.2.1. Stringent regulations
      • 5.2.2.2. Dearth of skilled neurosurgeons
    • 5.2.3. KEY MARKET OPPORTUNITIES
      • 5.2.3.1. Increasing research activities in the field of neurovascular therapies
      • 5.2.3.2. Rising demand for minimally invasive neurosurgical procedures
  • 5.3. ONGOING CLINICAL STUDIES
    • 5.3.1. EMBOLIZATION COILING PROCEDURES
    • 5.3.2. CAROTID ARTERY STENTING PROCEDURES
    • 5.3.3. EMBOLIC PROTECTION PROCEDURES
    • 5.3.4. FLOW DIVERSION PROCEDURES
    • 5.3.5. SUPPORTING TECHNIQUES
    • 5.3.6. NEUROTHROMBECTOMY PROCEDURES

6. INDUSTRY INSIGHTS

  • 6.1. INTRODUCTION
  • 6.2. SUPPLY CHAIN ANALYSIS
  • 6.3. PORTER'S FIVE FORCES ANALYSIS
  • 6.4. INDUSTRY TRENDS
    • 6.4.1. INCREASING AWARENESS AMONG SURGEONS ABOUT BENEFITS OF STEREOTACTIC FRAMEWORK PROCEDURES IN NEUROSURGERIES
    • 6.4.2. CHANNEL OPTIMIZATION

7. NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET,

BY PRODUCT 78

  • 7.1. INTRODUCTION
  • 7.2. ANEURYSM COILING & EMBOLIZATION DEVICES
    • 7.2.1. EMBOLIC COILS
      • 7.2.1.1. Bare detachable coils
      • 7.2.1.2. Coated detachable coils
    • 7.2.2. FLOW DIVERSION DEVICES
    • 7.2.3. LIQUID EMBOLIC AGENTS
  • 7.3. CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS
    • 7.3.1. CAROTID ARTERY STENTS
    • 7.3.2. EMBOLIC PROTECTION SYSTEMS
      • 7.3.2.1. Distal filter devices
      • 7.3.2.2. Balloon occlusion devices
  • 7.4. SUPPORT DEVICES
    • 7.4.1. MICROCATHETERS
    • 7.4.2. MICROGUIDEWIRES
  • 7.5. NEUROTHROMBECTOMY DEVICES
    • 7.5.1. CLOT RETRIEVAL DEVICES
    • 7.5.2. SUCTION AND ASPIRATION DEVICES
    • 7.5.3. SNARES

8. GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY DISEASE PATHOLOGY

  • 8.1. INTRODUCTION
  • 8.2. ISCHEMIC STROKES
  • 8.3. CEREBRAL ANEURYSMS
  • 8.4. ARTERIOVENOUS MALFORMATION AND FISTULAS
  • 8.5. OTHER DISEASE PATHOLOGIES

9. GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
      • 9.2.1.1. U.S.
      • 9.2.1.2. Canada
  • 9.3. EUROPE
      • 9.3.1.1. Germany
      • 9.3.1.2. France
      • 9.3.1.3. U.K.
      • 9.3.1.4. Rest of Europe
  • 9.4. ASIA-PACIFIC
      • 9.4.1.1. Japan
      • 9.4.1.2. China
      • 9.4.1.3. India
      • 9.4.1.4. Rest of Asia-Pacific
  • 9.5. REST OF THE WORLD (ROW)

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. MARKET SHARE ANALYSIS
  • 10.3. COMPETITIVE SCENARIO
  • 10.4. RECENT DEVELOPMENTS
    • 10.4.1. PRODUCT LAUNCHES
    • 10.4.2. STRATEGIC ACQUISITIONS
    • 10.4.3. EXPANSIONS
    • 10.4.4. AGREEMENTS AND COLLABORATIONS
    • 10.4.5. OTHER DEVELOPMENTS

11. COMPANY PROFILES (Business Overview, Products offered, Key Insights, Recent Developments, MnM View)*

  • 11.1. INTRODUCTION
    • 11.1.1. GEOGRAPHIC BENCHMARKING
  • 11.2. STRYKER CORPORATION
  • 11.3. MEDTRONIC PLC
  • 11.4. JOHNSON & JOHNSON
  • 11.5. TERUMO CORPORATION
  • 11.6. PENUMBRA, INC.
  • 11.7. BOSTON SCIENTIFIC CORPORATION
  • 11.8. MICROPORT SCIENTIFIC CORPORATION
  • 11.9. MERIT MEDICAL SYSTEMS, INC.
  • 11.10. W.L. GORE & ASSOCIATES, INC.
  • 11.11. ABBOTT LABORATORIES

*Details on Business Overview, Products offered, Key Insights, Recent Developments, MnM View might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. INSIGHTS OF INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.5. AVAILABLE CUSTOMIZATIONS
  • 12.6. RELATED REPORTS
  • 12.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: EMBOLIZATION COILS: ONGOING CLINICAL TRIALS (AS OF DECEMBER 2016)
  • TABLE 2: CAROTID STENTS: ONGOING CLINICAL TRIALS (AS OF DECEMBER 2016)
  • TABLE 3: DISTAL FILTER AND BALLOON OCCLUSION CATHETERS: ONGOING CLINICAL TRIALS (AS OF DECEMBER 2016)
  • TABLE 4: FLOW DIVERSION DEVICES: ONGOING CLINICAL TRIALS (AS OF DECEMBER 2016)
  • TABLE 5: MICROCATHETERS: ONGOING CLINICAL TRIALS (AS OF DECEMBER 2016)
  • TABLE 6: CLOT RETRIEVAL, SUCTION, AND ASPIRATION DEVICES: ONGOING CLINICAL TRIALS (AS OF DECEMBER 2016)
  • TABLE 7: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 8: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 9: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (UNITS)
  • TABLE 10: GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 11: GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (UNITS)
  • TABLE 12: GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 13: EMBOLIC COILS: GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 14: EMBOLIC COILS: GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (UNITS)
  • TABLE 15: EMBOLIC COILS: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 16: BARE DETACHABLE COILS: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 17: BARE DETACHABLE COILS: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY REGION, 2014-2021 (UNITS)
  • TABLE 18: COATED DETACHABLE COILS: GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 19: COATED DETACHABLE COILS: GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY REGION, 2014-2021 (UNITS)
  • TABLE 20: FLOW DIVERSION DEVICES: GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 21: FLOW DIVERSION DEVICES: GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY REGION, 2014-2021 (UNITS)
  • TABLE 22: LIQUID EMBOLIC AGENTS: GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 23: LIQUID EMBOLIC AGENTS: GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY REGION, 2014-2021 (UNITS)
  • TABLE 24: CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 25: CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY TYPE, 2014-2021 (UNITS)
  • TABLE 26: GLOBAL CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 27: CAROTID ARTERY STENTS: GLOBAL CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 28: CAROTID ARTERY STENTS: GLOBAL CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (UNITS)
  • TABLE 29: EMBOLIC PROTECTION SYSTEMS: CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 30: EMBOLIC PROTECTION SYSTEMS: CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY TYPE, 2014-2021 (UNITS)
  • TABLE 31: EMBOLIC PROTECTION SYSTEMS: CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 32: DISTAL FILTER DEVICES: CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 33: DISTAL FILTER DEVICES: CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (UNITS)
  • TABLE 34: BALLOON OCCLUSION DEVICES: EMBOLIC PROTECTION SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 35: BALLOON OCCLUSION DEVICES: EMBOLIC PROTECTION SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (UNITS)
  • TABLE 36: SUPPORT DEVICES: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 37: SUPPORT DEVICES: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY TYPE, 2014-2021 (UNITS)
  • TABLE 38: SUPPORT DEVICES: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 39: MICROCATHETERS: NEUROVASCULAR SUPPORT DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 40: MICROCATHETERS: NEUROVASCULAR SUPPORT DEVICES MARKET SIZE, BY REGION, 2014-2021 (UNITS)
  • TABLE 41: MICROGUIDEWIRES: NEUROVASCULAR SUPPORT DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 42: MICROGUIDEWIRES: NEUROVASCULAR SUPPORT DEVICES MARKET SIZE, BY REGION, 2014-2021 (UNITS)
  • TABLE 43: GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 44: GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY TYPE, 2014-2021 (UNITS)
  • TABLE 45: GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 46: CLOT RETRIEVERS: GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 47: CLOT RETRIEVERS: GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2014-2021 (UNITS)
  • TABLE 48: SUCTION & ASPIRATION DEVICES: GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 49: SUCTION & ASPIRATION DEVICES: GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2014-2021 (UNITS)
  • TABLE 50: SNARES: GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 51: SNARES: GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2014-2021 (UNITS)
  • TABLE 52: DISEASE PATHOLOGY: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, 2014-2021 (USD MILLION)
  • TABLE 53: DISEASE PATHOLOGY: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 54: ISCHEMIC STROKES PATHOLOGY: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 55: CEREBRAL ANEURYSMS PATHOLOGY: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 56: ARTERIOVENOUS MALFORMATION AND FISTULAS PATHOLOGY: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 57: OTHER DISEASE PATHOLOGIES: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 58: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 59: NORTH AMERICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 60: NORTH AMERICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 61: NORTH AMERICA: ANEURYSM COILING AND EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT , 2014-2021 (USD MILLION)
  • TABLE 62: NORTH AMERICA: CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 63: NORTH AMERICA: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 64: NORTH AMERICA: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 65: NORTH AMERICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY DISEASE PATHOLOGY, 2014-2021 (USD MILLION)
  • TABLE 66: U.S.: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 67: CANADA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 68: EUROPE: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 69: EUROPE: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 70: EUROPE: ANEURYSM COILING AND EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 71: EUROPE: CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY PRODUCT , 2014-2021 (USD MILLION)
  • TABLE 72: EUROPE: SUPPORT DEVICES MARKET SIZE, BY PRODUCT , 2014-2021 (USD MILLION)
  • TABLE 73: EUROPE: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 74: EUROPE: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY DISEASE PATHOLOGY, 2014-2021 (USD MILLION)
  • TABLE 75: GERMANY: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 76: FRANCE: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 77: U.K.: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 78: ROE: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 79: ASIA-PACIFIC: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 80: ASIA-PACIFIC: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 81: ASIA-PACIFIC: ANEURYSM COILING AND EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 82: ASIA-PACIFIC: CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 83: ASIA-PACIFIC: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 84: ASIA-PACIFIC: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 85: ASIA-PACIFIC: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY DISEASE PATHOLOGY, 2014-2021 (USD MILLION)
  • TABLE 86: JAPAN: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 87: CHINA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 88: INDIA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 89: ROAPAC: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 90: ROW: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 91: ROW: ANEURYSM COILING AND EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 92: ROW: CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 93: ROW: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 94: ROW: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 95: ROW: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY DISEASE PATHOLOGY, 2014-2021 (USD MILLION)
  • TABLE 96: TOP PRODUCT LAUNCHES (2013-2016)
  • TABLE 97: TOP STRATEGIC ACQUISITIONS (2013-2016)
  • TABLE 98: TOP EXPANSIONS (2013-2016)
  • TABLE 99: TOP AGREEMENTS AND COLLABORATIONS (2013-2016)
  • TABLE 100: OTHER DEVELOPMENTS (2013-2016)

LIST OF FIGURES

  • FIGURE 1: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SEGMENTATION
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: GLOBAL STROKE PREVALENCE, BY COUNTRY, 2015
  • FIGURE 4: INCREASE IN GLOBAL GERIATRIC POPULATION, BY COUNTRY (2010-2015)
  • FIGURE 5: INCREASE IN PROPORTION OF GERIATRIC INDIVIDUALS IN OVERALL WORLD POPULATION, BY COUNTRY (2011-2030)
  • FIGURE 6: PERCENTAGE INCREASE IN GERIATRIC POPULATION IN TOTAL WORLD POPULATION, BY REGION (1980-2010 VS. 2010-2040)
  • FIGURE 7: GLOBAL HEALTHCARE EXPENDITURE, BY COUNTRY (2000 VS. 2014)
  • FIGURE 8: GLOBAL HEALTHCARE EXPENDITURE, BY REGION (2000 VS. 2014)
  • FIGURE 9: GLOBAL HEALTHCARE SPENDING MATRIX, BY KEY MARKET (2014)
  • FIGURE 10: BOTTOM-UP APPROACH
  • FIGURE 11: TOP-DOWN APPROACH
  • FIGURE 12: DATA TRIANGULATION
  • FIGURE 13: ASSUMPTIONS OF THE RESEARCH STUDY
  • FIGURE 14: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY PRODUCT (2016 VS. 2021)
  • FIGURE 15: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY PATHOLOGY (2016 VS. 2021)
  • FIGURE 16: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY REGION (2016 VS. 2021)
  • FIGURE 17: NORTH AMERICA TO DOMINATE GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET DURING 2016-2021
  • FIGURE 18: GROWING TARGET PATIENT POPULATION TO DRIVE MARKET DEMAND FOR INTERVENTIONAL NEUROLOGY PRODUCTS DURING 2016-2021
  • FIGURE 19: ANEURYSM COILING & EMBOLIZATION DEVICES TO DOMINATE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY PRODUCT, UNTIL 2021
  • FIGURE 20: EMBOLIC COILS TO CONTRIBUTE THE HIGHEST TO INTERVENTIONAL NEUROLOGY MARKET, BY PRODUCT, DURING 2016-2021 (USD MILLION)
  • FIGURE 21: ISCHEMIC STROKE SEGMENT TO LEAD GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY PATHOLOGY, DURING 2016-2021
  • FIGURE 22: CHINA AND INDIA TO BE THE FASTEST GROWING COUNTRIES IN GLOBAL INTERVENTIONAL NEUROLOGY MARKET DURING 2016-2021
  • FIGURE 23: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 24: PROPORTION OF GERIATRIC POPULATION TO TOTAL WORLD POPULATION, BY COUNTRY, (2012 VS. 2020)
  • FIGURE 25: GLOBAL TREND IN GOVERNMENT HEALTHCARE EXPENDITURE: DEVELOPED VS. DEVELOPING COUNTRIES (2010 VS. 2014)
  • FIGURE 26: ONGOING CLINICAL TRIALS IN GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET (AS OF DECEMBER 2016)
  • FIGURE 27: SUPPLY CHAIN ANALYSIS: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET (AS OF 2016)
  • FIGURE 28: PORTER'S FIVE FORCES ANALYSIS (2016): GROWING ADOPTION OF NEUROVASCULAR PRODUCTS TRANSLATING INTO HIGHER MARKET DEMAND
  • FIGURE 29: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS TO RECORD HIGHEST GROWTH DURING 2016-2021 (USD MILLION)
  • FIGURE 30: EMBOLIC COILS SEGMENT TO LEAD ANEURYSM COILING AND EMBOLIZATION DEVICES MARKET DURING 2016-2021 (USD MILLION)
  • FIGURE 31: CAROTID ARTERY STENTS SEGMENT TO RECORD HIGHEST GROWTH IN CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET UNTIL 2021 (USD MILLION)
  • FIGURE 32: MICROCATHETERS TO HOLD LARGEST SHARE OF SUPPORT DEVICES SEGMENT DURING 2016-2021 (USD MILLION)
  • FIGURE 33: CLOT RETRIEVERS TO RECORD HIGHEST GROWTH IN NEUROTHROMBECTOMY DEVICES MARKET, BY TYPE, DURING 2016-2021 (USD MILLION)
  • FIGURE 34: ISCHEMIC STROKE TO RECORD FASTEST GROWTH IN NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY DISEASE PATHOLOGY, DURING 2016-2021 (USD MILLION)
  • FIGURE 35: NORTH AMERICA TO DOMINATE GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET FOR ISCHEMIC STROKES TILL 2021 (USD MILLION)
  • FIGURE 36: NORTH AMERICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SNAPSHOT
  • FIGURE 37: EUROPE: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SNAPSHOT
  • FIGURE 38: ASIA-PACIFIC: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SNAPSHOT
  • FIGURE 39: ROW: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SNAPSHOT
  • FIGURE 40: PRODUCT LAUNCHES & COMMERCIALIZATION THE KEY GROWTH STRATEGY ADOPTED BY MAJORITY OF MARKET PLAYERS BETWEEN 2013 AND 2016
  • FIGURE 41: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SHARE, BY KEY PLAYERS (2015)
  • FIGURE 42: GROWING NUMBER OF PRODUCT LAUNCHES AND ENHANCEMENTS DRIVING MARKET GROWTH
  • FIGURE 43: GEOGRAPHIC REVENUE MIX OF TOP FOUR PLAYERS IN GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET
  • FIGURE 44: STRYKER CORPORATION: COMPANY SNAPSHOT (2015)
  • FIGURE 45: MEDTRONIC PLC: COMPANY SNAPSHOT (2015)
  • FIGURE 46: JOHNSON & JOHNSON: COMPANY SNAPSHOT (2015)
  • FIGURE 47: TERUMO CORPORATION: COMPANY SNAPSHOT (2015)
  • FIGURE 48: PENUMBRA, INC.: COMPANY SNAPSHOT (2015)
  • FIGURE 49: BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2015)
  • FIGURE 50: MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2015)
  • FIGURE 51: MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2015)
  • FIGURE 52: ABBOTT LABORATORIES: COMPANY SNAPSHOT (2015)
Back to Top